PM2.5 Promotes Epithelial Cytokine Release in Allergic Rhinitis via AhR/ROS/p53 Pathway-Mediated Nasal Epithelial Cell Senescence

Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

Expression and Clinical Diagnostic Value of Granzyme K in Non-Eosinophilic Chronic Rhinosinusitis with Nasal Polyps

Finegoldia magna as a Key Microbial Correlate of Sinus Bone Destruction in Chronic Rhinosinusitis

The elongated ciliated cells derived from nasal polyp are distinctly different from ciliated 1 cells in different parts of the nasal mucosa

Vitamin D Supplementation Enhances the Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

Three-Year Longitudinal Evaluation of Timing Effects on Subcutaneous Immunotherapy Efficacy and Safety in Allergic Rhinitis

Scrape-Out Checklist for CT image reviewing before Sinus Surgery

Rethinking Monotherapy in Chronic Rhinosinusitis with Nasal Polyps: Dual- and Multispecific Antibodies

Intranasal PAMAM-G3 scavenges cell-free DNA attenuating the allergic airway inflammation

Synergistic Effects of Pollen and Thunderstorms on Healthcare Visits for Allergic Rhinitis and Asthma: A Four-City Time-Series Study in Northwest China

A pH-Responsive Metformin-Loaded Hydrogel (Met@Gel) Disrupts the Senescence-STING-Inflammation Axis in Non-Eosinophilic Chronic Rhinosinusitis

Bacterial lysates add-on therapy to reduce Postoperative Recurrence in Nasal Polyps

开场致辞

开场致辞

AIT治疗最新进展

一、AIT治疗的价值和意义，目前耳鼻喉科的临床障碍点
二、加速免疫疗法，对临床的意义、安全性和患者类型选择
三、应该在什么时间节点评估免疫治疗的疗效，最佳评价标准是什么

AIT与生物制剂协同治疗机制与临床获益

一、从免疫学的角度AIT与生物制剂联合的临床价值与定位
二、AIT与生物制剂联合的用药时机与生物制剂停药时机

总结